<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Noncardiac surgery in adults with aortic stenosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Noncardiac surgery in adults with aortic stenosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Noncardiac surgery in adults with aortic stenosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kim A Eagle, MD, MACC</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sarah Kohnstamm, MD, FACC</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Catherine M Otto, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 19, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Risk models have identified severe aortic stenosis (AS) as a major clinical predictor of adverse outcomes [<a href="#rid1">1</a>]. Population studies from the United States and Europe have reported AS in approximately 1 to 2 percent of individuals 65 to 75 years old, with prevalence increasing to 3 to 8 percent in individuals ≥75 years old and 18 percent in those &gt;90 years old [<a href="#rid2">2-8</a>]. In the Helsinki Aging study, nearly 3 percent of the individuals between 75 and 86 years of age had critical AS [<a href="#rid3">3</a>]. Concurrent cardiovascular disease has been identified in more than 50 percent of patients with AS &gt;70 years and in 65 percent in those &gt;80 years [<a href="#rid9">9,10</a>]. (See  <a class="medical medical_review" href="/d/html/8164.html" rel="external">"Clinical manifestations and diagnosis of aortic stenosis in adults"</a> and  <a class="medical medical_review" href="/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a> and  <a class="medical medical_review" href="/d/html/8147.html" rel="external">"Valvular heart disease in older adults", section on 'Underlying atherosclerosis'</a>.)</p><p>The presence of valvular disease has potentially important implications for perioperative management as well as perioperative risk. Preoperative considerations and postoperative management of patients with native AS undergoing noncardiac surgery will be reviewed here.</p><p>Intraoperative management of patients with AS is reviewed separately. (See  <a class="medical medical_review" href="/d/html/93514.html" rel="external">"Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>AS results in fixed obstruction to left ventricular (LV) emptying. The stenotic process is usually gradual in onset and progression, giving the heart ample opportunity to adapt. The LV myocardium hypertrophies over time, resulting in the generation of greater pressure during systole, which forces blood past the fixed mechanical obstruction. As a result, the cardiac output and LV end-diastolic volume are maintained and patients can remain asymptomatic for a prolonged period of time, even with severe AS. (See  <a class="medical medical_review" href="/d/html/8164.html" rel="external">"Clinical manifestations and diagnosis of aortic stenosis in adults"</a> and  <a class="medical medical_review" href="/d/html/8165.html" rel="external">"Natural history, epidemiology, and prognosis of aortic stenosis"</a>.)</p><p>However, the chronic pressure overload state that results in the compensatory concentric LV hypertrophy also reduces the compliance of the LV. As a result, diastolic dysfunction develops over time, the end diastolic pressure of the LV increases, and patients eventually develop symptoms of dyspnea. The concentric hypertrophy also reduces coronary flow reserve, rendering the patient more susceptible to chest pain from ischemia in situations of increased myocardial oxygen demand, even in the absence of obstructive coronary artery disease [<a href="#rid11">11</a>]. In addition, due to fixed obstruction of the LV outflow tract, decreases in systemic vascular resistance can result in hypotension with subsequent ischemia from reduced coronary perfusion, ultimately manifesting in presyncope or syncope. (See  <a class="medical medical_review" href="/d/html/8164.html" rel="external">"Clinical manifestations and diagnosis of aortic stenosis in adults"</a>.)</p><p>Therefore, rapid clinical deterioration can occur in patients even with asymptomatic AS during the hemodynamic stress associated with both the anesthetic and surgical stress of noncardiac surgery (as well as other states that require augmentation of cardiac output, such as infection, anemia, or pregnancy).</p><p class="headingAnchor" id="H7"><span class="h1">PREOPERATIVE ASSESSMENT</span></p><p class="headingAnchor" id="H9305917"><span class="h2">Key steps</span><span class="headingEndMark"> — </span>The following are key steps in the management of patients with suspected AS who need noncardiac surgery:</p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation of symptoms and signs of cardiac disease</p><p class="bulletIndent1"><span class="glyph">●</span>Preoperative echocardiographic assessment of AS severity and LV function</p><p class="bulletIndent1"><span class="glyph">●</span>Careful evaluation for coexisting coronary artery disease (CAD) and other cardiac risk factors  (<a class="graphic graphic_table graphicRef57075" href="/d/graphic/57075.html" rel="external">table 1</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Estimation of the risk of noncardiac surgery</p><p></p><p>The above evaluation will enable recognition of AS, determination of its severity, and identification of any concomitant cardiac disease.</p><p class="headingAnchor" id="H9306402"><span class="h2">Recognition of AS</span><span class="headingEndMark"> — </span>Recognition of AS is a key step in preoperative assessment. Many adverse events occur because the diagnosis of AS was not known to the surgical team. Preoperative echocardiography should be performed for evaluation of any murmur that is not clearly benign based on history and physical exam.</p><p>AS may be initially recognized on physical examination by the presence of a systolic "ejection" murmur  (<a class="graphic graphic_movie graphicRef67896 graphicRef77091" href="/d/graphic/67896.html" rel="external">movie 1A-B</a>). A functional murmur should be distinguished from a pathologic murmur with a careful physical examination that includes cardiac maneuvers (see  <a class="medical medical_review" href="/d/html/1078.html" rel="external">"Auscultation of cardiac murmurs in adults"</a> and  <a class="medical medical_review" href="/d/html/1080.html" rel="external">"Physiologic and pharmacologic maneuvers in the differential diagnosis of heart murmurs and sounds"</a>). The physical examination may also reveal one or more associated findings. These findings are briefly summarized here and are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/8164.html" rel="external">"Clinical manifestations and diagnosis of aortic stenosis in adults", section on 'Physical examination'</a>.)</p><p>The murmur of aortic valve sclerosis, a common and more benign valvular abnormality seen in older individuals, is also a midsystolic murmur. In general, the murmur is brief and not very loud. A normal carotid pulse and normal S2 usually confirm the absence of AS. (See  <a class="medical medical_review" href="/d/html/8123.html" rel="external">"Aortic valve sclerosis and pathogenesis of calcific aortic stenosis"</a>.)</p><p>Studies evaluating the precision and accuracy of the clinical examination found that four findings were useful for diagnosis of AS [<a href="#rid12">12-14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A slow rate of rise and reduced peak in the carotid pulse</p><p class="bulletIndent1"><span class="glyph">●</span>Mid to late peak intensity of the murmur</p><p class="bulletIndent1"><span class="glyph">●</span>Maximal murmur intensity at the second right intercostal space</p><p class="bulletIndent1"><span class="glyph">●</span>Reduced intensity of the second heart sound or single S2</p><p></p><p>Echocardiography enables assessment of disease severity and is necessary since none of the physical findings have both a high sensitivity and high specificity for severe valvular obstruction [<a href="#rid12">12,13</a>]. Although classic findings are helpful in identifying patients with significant AS, the physical examination is less useful for estimating hemodynamic severity.</p><p class="headingAnchor" id="H9306332"><span class="h2">Evaluation of AS severity</span><span class="headingEndMark"> — </span>Evaluation of the AS patient includes history, physical examination, echocardiography, and assessment of any concomitant cardiovascular disease, as discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/8164.html" rel="external">"Clinical manifestations and diagnosis of aortic stenosis in adults"</a> and  <a class="medical medical_review" href="/d/html/8114.html" rel="external">"Clinical manifestations and diagnosis of low gradient severe aortic stenosis"</a> and  <a class="medical medical_review" href="/d/html/8115.html" rel="external">"Aortic valve area in aortic stenosis in adults"</a> and  <a class="medical medical_review" href="/d/html/5295.html" rel="external">"Echocardiographic evaluation of the aortic valve"</a>.)</p><p>As noted in the 2014 American College of Cardiology/American Heart Association (ACC/AHA) perioperative guideline, patients with clinically suspected moderate or greater degrees of valvular stenosis or regurgitation should undergo preoperative echocardiography if there has been either 1) no prior echocardiography within one year or 2) a significant change in clinical status or physical examination since the last evaluation [<a href="#rid1">1</a>].</p><p>The 2020 ACC/AHA valvular heart disease guideline classifies valvular heart disease into one of four stages (A to D) based on valve morphology, the presence or absence of symptoms, hemodynamic severity of disease, and the impact of the valve lesion on ventricular function. Those with stage A AS are considered at risk for progression (eg, those with bicuspid aortic valve or aortic sclerosis); stage B, mild to moderate severity disease, but asymptomatic; stage C1, severe disease, but asymptomatic and compensated right and LV function; stage C2, severe, but asymptomatic with decompensation of right and/or LV function; and stage D, hemodynamically severe and symptomatic  (<a class="graphic graphic_table graphicRef95224" href="/d/graphic/95224.html" rel="external">table 2</a>) [<a href="#rid15">15</a>]. Though symptomatic severe AS is usually associated with a high gradient (stage D1), severe AS may also exist with a low gradient due to either low flow associated with reduced LV ejection fraction (stage D2) or with normal LV ejection fraction associated with normal flow or paradoxical low flow (D3). (See  <a class="medical medical_review" href="/d/html/8164.html" rel="external">"Clinical manifestations and diagnosis of aortic stenosis in adults"</a> and  <a class="medical medical_review" href="/d/html/8114.html" rel="external">"Clinical manifestations and diagnosis of low gradient severe aortic stenosis"</a>.)</p><p class="headingAnchor" id="H25097190"><span class="h2">Evaluation of CAD</span><span class="headingEndMark"> — </span>We recommend assessment of the presence of CAD in patients with AS prior to elective noncardiac surgery when the patient is symptomatic with chest pain or angina equivalent, has evidence of heart failure (HF) that has not been previously assessed, or has evidence of a recent acute coronary syndrome. In patients requiring urgent or emergency surgery, the evaluation for obstructive CAD should not delay a necessary noncardiac operation. (See  <a class="medical medical_review" href="/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a>.)</p><p>In patients without valvular heart disease, the preoperative assessment for CAD is made on the basis of symptoms and functional capacity. Given the physiologic changes that occur in patients with AS (LV hypertrophy, diastolic dysfunction, alterations in coronary flow reserve), the cause of cardiac symptoms (ie, obstructive CAD versus valvular disease) can be difficult to differentiate. (See  <a class="medical medical_review" href="/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a>.)</p><p>Further complicating this issue is the frequency of concomitant AS and CAD, with the prevalence of both increasing with age. Among older patients with symptomatic AS, the prevalence of CAD is 40 to 50 percent in those with typical angina and 20 percent in those without chest pain. Even in patients with AS who are less than 40 and have no chest pain and no coronary risk factors, the prevalence of CAD may be as high as 5 percent [<a href="#rid16">16-19</a>]. (See  <a class="medical medical_review" href="/d/html/8164.html" rel="external">"Clinical manifestations and diagnosis of aortic stenosis in adults"</a>.)</p><p>The following considerations guide the choice of test in patients with AS undergoing evaluation for CAD:</p><p class="bulletIndent1"><span class="glyph">●</span>Given the importance of determining the presence of CAD, coronary angiography remains the most appropriate method for the definitive diagnosis of CAD in patients with severe AS with risk factors or symptoms that might be due to coronary disease. (See  <a class="medical medical_review" href="/d/html/8154.html" rel="external">"Indications for valve replacement for high gradient aortic stenosis in adults", section on 'Coronary angiography prior to valve surgery'</a>.)</p><p></p><p class="bulletIndent1">Furthermore, if echocardiographic assessment is inconclusive, a left heart catheterization can provide direct hemodynamic measurements of the aortic valve gradient. Since there is some risk of cerebral embolization associated with crossing a calcified stenotic aortic valve [<a href="#rid20">20,21</a>], retrograde catheterization of the aortic valve is performed only when needed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Electrocardiogram (ECG) stress testing alone is generally not sufficient for evaluation of CAD in patients with AS [<a href="#rid15">15</a>]. The resting and exercise ECG in patients with valvular heart disease frequently shows ST-segment changes due to LV hypertrophy, LV chamber dilatation, or bundle-branch block, which reduces the accuracy of the ECG at rest and during exercise for the diagnosis of concomitant CAD. In addition, caution should be used when exercising patients with severe AS, as postexercise vasodilatory responses can dramatically reduce preload and result in hemodynamic decompensation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9380" href="/d/drug information/9380.html" rel="external">Dobutamine</a> stress echocardiography or vasodilator radionuclide stress testing may be helpful in patients with mild or moderate AS. Although data are limited, small studies suggest that vasodilator radionuclide stress testing may be useful in patients with moderate or severe AS [<a href="#rid22">22-24</a>]. A study found that vasodilator stress in patients with severe AS was associated with an increased risk of a &gt;20 mmHg fall in systolic blood pressure and only moderate diagnostic accuracy (sensitivity of 77 percent and specificity of 69 percent) for detection of CAD, compared with coronary angiography [<a href="#rid25">25</a>]. In selected patients with a low to intermediate pretest probability of CAD, contrast-enhanced coronary computed tomographic angiography is an option. (See  <a class="medical medical_review" href="/d/html/1534.html" rel="external">"Stress testing for the diagnosis of obstructive coronary heart disease"</a> and  <a class="medical medical_review" href="/d/html/1502.html" rel="external">"Selecting the optimal cardiac stress test"</a> and  <a class="medical medical_review" href="/d/html/129395.html" rel="external">"Clinical use of coronary computed tomographic angiography"</a>.) </p><p></p><p>Stress testing is also used for purposes other than evaluation of CAD in specific populations of patients with AS. The use of exercise testing to evaluate asymptomatic patients with AS and the use of low-dose <a class="drug drug_general" data-topicid="9380" href="/d/drug information/9380.html" rel="external">dobutamine</a> stress testing in patients with low flow, low gradient AS are discussed separately. (See  <a class="medical medical_review" href="/d/html/8164.html" rel="external">"Clinical manifestations and diagnosis of aortic stenosis in adults", section on 'Asymptomatic sedentary patients'</a> and  <a class="medical medical_review" href="/d/html/8114.html" rel="external">"Clinical manifestations and diagnosis of low gradient severe aortic stenosis", section on 'Low-dose dobutamine stress echocardiogram'</a>.)</p><p class="headingAnchor" id="H9307098"><span class="h2">Estimation of risk of noncardiac surgery</span></p><p class="headingAnchor" id="H9306874"><span class="h3">Risk factors</span><span class="headingEndMark"> — </span>The risk of perioperative cardiac complications from noncardiac surgery in patients with AS varies with the severity of AS, the presence of cardiac symptoms, and the presence of other cardiac risk factors  (<a class="graphic graphic_table graphicRef57075" href="/d/graphic/57075.html" rel="external">table 1</a>), including ischemic heart disease and moderate or severe mitral regurgitation [<a href="#rid26">26,27</a>] (see <a class="local">'Evaluation of CAD'</a> above). The risk of noncardiac surgery is also dependent upon the risk category of the surgical procedure; minor procedures with local anesthesia entail less risk. Perioperative complications include myocardial infarction (MI), hypotension, HF, arrhythmias, and death.</p><p>General issues related to the estimation and management of cardiac risk prior to noncardiac surgery, including initial risk assessment, the role of noninvasive testing and possible cardiac catheterization, and the indications for beta blocker and statin therapy, are discussed separately (see  <a class="medical medical_review" href="/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a> and  <a class="medical medical_review" href="/d/html/6615.html" rel="external">"Management of cardiac risk for noncardiac surgery"</a>). However, most preoperative risk models do not include AS as a risk factor because this condition was not adequately represented in the populations from which these risk assessment tools were generated.</p><p>The perceived risk of complications in AS patients likely contributes to this underrepresentation, as patients are either deemed ineligible or referred for aortic valve replacement or valvotomy prior to surgery [<a href="#rid28">28</a>]. While the risk of adverse outcomes after major surgery in patients with valvular heart disease was reported as early as the 1960s [<a href="#rid29">29</a>], the association of AS with cardiac complications of noncardiac surgery was first established in the 1977 study that led to the initial Goldman cardiac risk index of noncardiac surgical procedures [<a href="#rid30">30,31</a>]. This study, like many that have followed, failed to distinguish between different severities of AS or between asymptomatic and symptomatic patients.</p><p>For example, perioperative risk of noncardiac surgery was compared in a 2005 study of 5149 AS patients identified based on International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes with severity not specified and 10,284 controls from the National Hospital Discharge Survey database [<a href="#rid32">32</a>]. The risk of MI was significantly higher in patients with AS compared with controls (3.9 versus 2.0 percent), and the presence of AS conferred a higher risk of MI even after correcting for sex, CAD, hypertension, and diabetes mellitus in a multivariate logistic regression model (odds ratio 1.55, 95% CI 1.27-1.9).</p><p>Lack of stratification of AS severity or symptomatology and heterogeneity in their evaluation and reporting have led to estimates as wide as 10 to 30 percent for the risk of cardiac complications after noncardiac surgery. These figures may complicate decision-making for clinicians and lead to unwarranted delay or cancellation of essential surgical procedures.</p><p>Later studies have focused on stratifying risk based on AS severity and symptoms, as illustrated by the following studies:</p><p class="bulletIndent1"><span class="glyph">●</span>In a retrospective study from the Netherlands of 108 patients with moderate or severe AS and 216 controls [<a href="#rid26">26</a>], a composite outcome of perioperative mortality and nonfatal MI not only occurred more frequently in AS patients than controls (14 versus 2 percent) but also in those with severe AS compared with moderate AS (31 versus 11 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A Mayo Clinic Scottsdale study compared perioperative outcomes of noncardiac surgery for 30 patients with asymptomatic severe AS with those for 60 controls with mild to moderate AS [<a href="#rid33">33</a>]. Postoperative events were more frequent in those with severe AS compared with those with mild to moderate AS, although the result did not reach statistical significance (33 versus 23 percent; p = 0.06).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 244 patients with severe AS and 390 patients with moderate AS undergoing noncardiac surgery at the Cleveland Clinic from 1998 to 2009 [<a href="#rid27">27</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mortality was 2.1 percent for AS patients compared with 1.0 percent in controls without AS. Likewise, postoperative MI was more frequent in patients with AS compared with controls (3.0 versus 1.1 percent).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>When stratified by symptomatology, patients with symptomatic severe AS had mortality of 2.8 percent as compared with 1.2 percent in those with asymptomatic severe AS. Similarly, postoperative MI occurred in 5.6 percent of patients with symptomatic severe AS and 3.5 percent in patients with asymptomatic severe AS.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An analysis of 256 patients with severe AS undergoing intermediate- or high-risk surgery at the Mayo Clinic from 2000 to 2010 yielded the following results [<a href="#rid34">34</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>There was no significant difference in 30-day mortality (5.9 versus 3.1 percent) in patients with severe AS compared with controls matched for age, sex, and year of surgery. However, mortality was significantly higher in patients with symptomatic severe AS compared with those with asymptomatic severe AS (9.4 versus 3.3 percent).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with severe AS experienced more major adverse cardiovascular events in 30 days (18.8 versus 10.5 percent), an outcome dominated by HF. Major adverse cardiovascular events were more frequent in symptomatic AS patients than in asymptomatic AS patients (28.3 versus 12 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In multivariable analysis, the following were predictors of postoperative death: emergency surgery (the strongest predictor), atrial fibrillation, and serum creatinine levels of &gt;2 mg/dL.</p><p></p><p>Finally, a systematic review and meta-analysis of nine studies of severe AS (including most of those listed above) with 29,327 participants found no difference in postoperative mortality between AS patients and controls. However, there was an increase in the composite adverse outcome as defined in each individual study, with a risk ratio (RR) of 2.30 (95% CI 1.33-3.97). When looking at patients with AS of any severity, the risk ratio versus control was lower (RR 1.64, 95% CI 1.23-2.19). The lowest risk of composite adverse outcome was seen in patients with asymptomatic AS (RR 1.59, 95% CI 1.19-2.12, p = 0.002) [<a href="#rid35">35</a>].</p><p>Stratification of AS by severity and symptomatology has been incorporated into the ACC/AHA and European Society of Cardiology guidelines. The former recommend (class IIa) "moderate-risk elective noncardiac surgery with appropriate intraoperative and postoperative hemodynamic monitoring" in patients with asymptomatic severe AS, whereas the latter recommend management of severe AS patients based on the presence or absence of symptoms. (See <a class="local">'Society guideline links'</a> below.)</p><p class="headingAnchor" id="H9306881"><span class="h3">Increased risk of bleeding</span><span class="headingEndMark"> — </span>Patients with moderate to severe AS have a bleeding tendency due to an acquired von Willebrand syndrome, which may increase the risk associated with noncardiac surgery [<a href="#rid36">36</a>]. Specifically, Heyde syndrome describes the increased risk of gastrointestinal bleeding from angiodysplasia associated with AS [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/d/html/8164.html" rel="external">"Clinical manifestations and diagnosis of aortic stenosis in adults", section on 'Bleeding tendency'</a>.)</p><p class="headingAnchor" id="H9306534"><span class="h1">PREOPERATIVE MANAGEMENT</span></p><p class="headingAnchor" id="H9306542"><span class="h2">Decisions before noncardiac surgery</span><span class="headingEndMark"> — </span>The above preoperative assessment will enable estimation of the risk of noncardiac surgery and determination of whether preoperative valve intervention is indicated. The necessity of the proposed noncardiac surgery should be carefully evaluated.</p><p>As noted in both the 2020 American Heart Association/American College of Cardiology (AHA/ACC) valve guidelines and the 2017 European Society of Cardiology (ESC) valve guidelines, low or moderate-risk elective noncardiac surgery with appropriate intraoperative monitoring and postoperative hemodynamic monitoring (including right heart catheter and/or intraoperative transesophageal echocardiography) is reasonable to perform in patients with asymptomatic severe AS [<a href="#rid15">15,38</a>]. As discussed above, observational data suggest that, with careful management, selected patients with AS, particularly those with asymptomatic disease and without significant CAD or other valvular disease, can undergo noncardiac procedures with an acceptable risk [<a href="#rid26">26,27,32-34,39,40</a>]. The anesthesia team should be aware of the presence and severity of AS. (See  <a class="medical medical_review" href="/d/html/93514.html" rel="external">"Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease", section on 'Aortic stenosis'</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Patients with indications for AVR</span><span class="headingEndMark"> — </span>For patients with AS who have indications for aortic valve replacement (AVR by surgical AVR [SAVR] or transcatheter aortic valve implantation [TAVI]) such as symptomatic severe AS, stage D, or asymptomatic severe AS with LV ejection fraction &lt;50 percent), we recommend postponing elective noncardiac surgery since these conditions are significant risk factors for perioperative morbidity and mortality [<a href="#rid15">15,41,42</a>]. The indications for AVR (SAVR or TAVI) are the same as in the absence of planned noncardiac surgery [<a href="#rid1">1,15</a>]. (See  <a class="medical medical_review" href="/d/html/8154.html" rel="external">"Indications for valve replacement for high gradient aortic stenosis in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>The choice between SAVR or TAVI is discussed separately. (See  <a class="medical medical_review" href="/d/html/83110.html" rel="external">"Choice of intervention for severe calcific aortic stenosis"</a>.)</p><p></p><p class="bulletIndent1">SAVR prior to noncardiac surgery is not always feasible, as some patients require an urgent noncardiac procedure, some may be at high risk for adverse outcomes from valvular surgery, and some may decline aortic valve surgery.</p><p></p><p class="bulletIndent1">In a registry-based cohort study of 2238 patients undergoing TAVI between 2012 and 2020, 300 patients subsequently underwent noncardiac surgery (elective for 160 patients and urgent/emergency for 140 patients) [<a href="#rid43">43</a>]. The risk of a 30-day adverse clinical event after noncardiac surgery was approximately 20 percent, with a 30-day mortality rate of nearly 10 percent. Baseline patient characteristics and timing, urgency, and surgical risk category were not associated with composite outcomes of death, stroke, MI, or bleeding. However, suboptimal device performance, such as paravalvular regurgitation or prosthesis-patient mismatch, was associated with an increased risk of 30-day adverse outcomes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Options for patients who are unable to undergo aortic valve intervention include proceeding directly with the noncardiac surgery with careful perioperative management. The role of balloon aortic valvuloplasty (BAV) in these patients is uncertain. (See  <a class="medical medical_review" href="/d/html/83110.html" rel="external">"Choice of intervention for severe calcific aortic stenosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Limited observational data suggest that with careful perioperative hemodynamic monitoring and care appropriate for the valve lesion, including postoperative intensive care unit management, selected patients with severe AS who are not candidates for or decline AVR or TAVI can undergo noncardiac procedures at an acceptable risk, particularly in the absence of significant CAD [<a href="#rid26">26,27,32-34,39,40</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The role of percutaneous BAV in patients with severe AS requiring noncardiac surgery is uncertain and declining as routine availability of TAVI has increased. The use of percutaneous BAV is limited in older adults with AS because complications (eg, stroke, acute aortic regurgitation, and MI) occur in approximately 10 to 20 percent of patients. Restenosis and clinical deterioration occur in most cases within 6 to 12 months. Data are limited on the efficacy of this approach in general and as applied to preparation for noncardiac surgery (see  <a class="medical medical_review" href="/d/html/8141.html" rel="external">"Percutaneous balloon aortic valvotomy for native aortic stenosis in adults"</a>):</p><p></p><p class="bulletIndent2">Two small studies, each with only seven patients who had symptomatic AS, evaluated the outcomes in patients who underwent BAV prior to noncardiac surgery [<a href="#rid44">44,45</a>]. There were no deaths, strokes, or conduction abnormalities in either series. One patient developed a pseudoaneurysm of the femoral artery.</p><p></p><p class="bulletIndent2">The outcomes were not as good in a report of 15 patients with symptomatic severe AS who underwent either noncardiac surgery or an invasive diagnostic procedure following BAV [<a href="#rid46">46</a>]. There were adverse outcomes in five patients, including one fatality. Among the 14 patients who survived BAV, there were no adverse surgical outcomes associated with either the noncardiac surgery or subsequent invasive diagnostic procedure.</p><p></p><p class="bulletIndent1">The 2020 AHA/ACC valvular guidelines do not recommend routine BAV in the preoperative setting, with the possible exception of use in critically ill patients as a bridge to SAVR or TAVI. The 2017 European Society of Cardiology (ESC) guidelines note that TAVI (or BAV) may be considered in selected patients with symptomatic AS at high risk for adverse outcomes with valve surgery [<a href="#rid42">42</a>].</p><p></p><p class="headingAnchor" id="H3776735208"><span class="h1">INTRAOPERATIVE MANAGEMENT</span><span class="headingEndMark"> — </span>Intraoperative management for patients with AS undergoing noncardiac surgery is discussed separately  (<a class="graphic graphic_table graphicRef108941" href="/d/graphic/108941.html" rel="external">table 3</a>). (See  <a class="medical medical_review" href="/d/html/93514.html" rel="external">"Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease", section on 'Aortic stenosis'</a>.)</p><p class="headingAnchor" id="H4031969467"><span class="h1">POSTOPERATIVE MANAGEMENT</span><span class="headingEndMark"> — </span>The most important principles for postoperative management of patients with AS are volume management and management of arrhythmias. The observations below support these main treatment principles [<a href="#rid47">47,48</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Maintenance of normal sinus rhythm with a moderate heart rate is important. Because the atrial "kick" may provide up to 40 percent of ventricular filling in patients with diastolic dysfunction or reduced LV compliance, rhythms other than sinus rhythm can have deleterious hemodynamic effects.</p><p></p><p class="bulletIndent1">Atrial fibrillation (AF) with rapid ventricular response may be particularly poorly tolerated. If new-onset AF develops, reversible contributing factors (eg, electrolyte abnormalities or inadequate pain control) should be identified and addressed. Management of AF is dependent on symptoms, duration of AF, and need for rate or rhythm control, as discussed separately. Since stroke volume across the stenotic valve is relatively fixed, bradycardia (heart rate &lt;40 beat per minute) should also be avoided. (See  <a class="medical medical_review" href="/d/html/113847.html" rel="external">"Atrial fibrillation in patients undergoing noncardiac surgery", section on 'Postoperative atrial fibrillation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intravascular volume and preload must be maintained. Reductions in preload, as may be precipitated by sedative or analgesics drugs, may be poorly tolerated because of impaired LV compliance. However, gradual volume overload from postoperative shifts in intravascular volume, as well as the gradual accumulation of ongoing intravenous fluids or blood products, will be poorly tolerated and result in HF. Accurate assessment of a patient's intake and output balance is essential.</p><p></p><p class="headingAnchor" id="H65933329"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/115482.html" rel="external">"Society guideline links: Cardiac valve disease"</a> and  <a class="medical medical_society_guidelines" href="/d/html/115814.html" rel="external">"Society guideline links: Perioperative cardiovascular evaluation and management"</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk of noncardiac surgery in patients with AS</strong> – Patients with significant aortic stenosis (AS) are at increased risk for cardiac complications, including intraoperative hypotension, myocardial infarction, ischemia, heart failure, arrhythmias, and death. (See <a class="local">'Estimation of risk of noncardiac surgery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Perioperative risk factors</strong> – Perioperative risk increases with AS severity; the presence of cardiac symptoms; the presence of concomitant cardiac risk factors, including ischemic heart disease, which is prevalent in patients with AS; and the risk level of the surgical procedure. As a result, assessment of an individual patient’s risk is best thought of as a global cardiac risk assessment. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management for patients with asymptomatic severe AS</strong> – Observational data suggest that it is reasonable to perform moderate-risk elective noncardiac surgery with appropriate intraoperative and postoperative hemodynamic monitoring in patients with asymptomatic severe AS. (See <a class="local">'Decisions before noncardiac surgery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management for patients with symptomatic severe AS</strong> – Patients with symptomatic severe AS should have elective noncardiac surgery delayed when possible. Patients with indications for aortic valve replacement should generally undergo surgical AVR (SAVR) or transcatheter aortic valve implantation (TAVI) prior to elective noncardiac surgery. (See <a class="local">'Patients with indications for AVR'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Perioperative management of severe AS</strong> – Valve replacement is not feasible in some patients with indications for aortic valve surgery (eg, urgent or emergency life-saving surgery, multiple medical comorbidities, or patient refusal). Limited observational data suggest that perioperative risk can be managed with careful intraoperative monitoring in selected patients with severe, asymptomatic, or even symptomatic AS, particularly those with no significant coronary artery disease. (See <a class="local">'Preoperative management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Preoperative recognition of the severity of AS and any concomitant cardiac disease and communication with the anesthesiologist is essential. (See <a class="local">'Preoperative assessment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Postoperative management in patients with AS includes volume control and management of heart rate and rhythm. (See <a class="local">'Postoperative management'</a> above.)</p><p></p><p class="headingAnchor" id="H347417233"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff thank Anna M Booher, MD, and Prashant Vaishnava, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014; 64:e77.</a></li><li><a class="nounderline abstract_t">Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997; 29:630.</a></li><li><a class="nounderline abstract_t">Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21:1220.</a></li><li><a class="nounderline abstract_t">Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368:1005.</a></li><li><a class="nounderline abstract_t">Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011; 8:162.</a></li><li><a class="nounderline abstract_t">Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. the Tromsø study. Heart 2013; 99:396.</a></li><li><a class="nounderline abstract_t">Rezzoug N, Vaes B, de Meester C, et al. The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older. BMC Cardiovasc Disord 2016; 16:7.</a></li><li><a class="nounderline abstract_t">Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013; 62:1002.</a></li><li><a class="nounderline abstract_t">Iung B. Interface between valve disease and ischaemic heart disease. Heart 2000; 84:347.</a></li><li><a class="nounderline abstract_t">Goel SS, Ige M, Tuzcu EM, et al. Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll Cardiol 2013; 62:1.</a></li><li><a class="nounderline abstract_t">Banovic MD, Vujisic-Tesic BD, Kujacic VG, et al. Coronary flow reserve in patients with aortic stenosis and nonobstructed coronary arteries. Acta Cardiol 2011; 66:743.</a></li><li><a class="nounderline abstract_t">Etchells E, Bell C, Robb K. Does this patient have an abnormal systolic murmur? JAMA 1997; 277:564.</a></li><li><a class="nounderline abstract_t">Etchells E, Glenns V, Shadowitz S, et al. A bedside clinical prediction rule for detecting moderate or severe aortic stenosis. J Gen Intern Med 1998; 13:699.</a></li><li><a class="nounderline abstract_t">Munt B, Legget ME, Kraft CD, et al. Physical examination in valvular aortic stenosis: correlation with stenosis severity and prediction of clinical outcome. Am Heart J 1999; 137:298.</a></li><li><a class="nounderline abstract_t">Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143:e72.</a></li><li><a class="nounderline abstract_t">Green SJ, Pizzarello RA, Padmanabhan VT, et al. Relation of angina pectoris to coronary artery disease in aortic valve stenosis. Am J Cardiol 1985; 55:1063.</a></li><li><a class="nounderline abstract_t">Chobadi R, Wurzel M, Teplitsky I, et al. Coronary artery disease in patients 35 years of age or older with valvular aortic stenosis. Am J Cardiol 1989; 64:811.</a></li><li><a class="nounderline abstract_t">Lombard JT, Selzer A. Valvular aortic stenosis. A clinical and hemodynamic profile of patients. Ann Intern Med 1987; 106:292.</a></li><li><a class="nounderline abstract_t">Rapp AH, Hillis LD, Lange RA, Cigarroa JE. Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris. Am J Cardiol 2001; 87:1216.</a></li><li><a class="nounderline abstract_t">Chambers J, Bach D, Dumesnil J, et al. Crossing the aortic valve in severe aortic stenosis: no longer acceptable? J Heart Valve Dis 2004; 13:344.</a></li><li><a class="nounderline abstract_t">Omran H, Schmidt H, Hackenbroch M, et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 2003; 361:1241.</a></li><li><a class="nounderline abstract_t">Samuels B, Kiat H, Friedman JD, Berman DS. Adenosine pharmacologic stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis. Diagnostic efficacy and comparison of clinical, hemodynamic and electrocardiographic variables with 100 age-matched control subjects. J Am Coll Cardiol 1995; 25:99.</a></li><li><a class="nounderline abstract_t">Patsilinakos SP, Spanodimos S, Rontoyanni F, et al. Adenosine stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis. J Nucl Cardiol 2004; 11:20.</a></li><li><a class="nounderline abstract_t">Demirkol MO, Yaymaci B, Debeş H, et al. Dipyridamole myocardial perfusion tomography in patients with severe aortic stenosis. Cardiology 2002; 97:37.</a></li><li><a class="nounderline abstract_t">Hussain N, Chaudhry W, Ahlberg AW, et al. An assessment of the safety, hemodynamic response, and diagnostic accuracy of commonly used vasodilator stressors in patients with severe aortic stenosis. J Nucl Cardiol 2017; 24:1200.</a></li><li><a class="nounderline abstract_t">Kertai MD, Bountioukos M, Boersma E, et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med 2004; 116:8.</a></li><li><a class="nounderline abstract_t">Agarwal S, Rajamanickam A, Bajaj NS, et al. Impact of aortic stenosis on postoperative outcomes after noncardiac surgeries. Circ Cardiovasc Qual Outcomes 2013; 6:193.</a></li><li><a class="nounderline abstract_t">Samarendra P, Mangione MP. Aortic stenosis and perioperative risk with noncardiac surgery. J Am Coll Cardiol 2015; 65:295.</a></li><li><a class="nounderline abstract_t">SKINNER JF, PEARCE ML. SURGICAL RISK IN THE CARDIAC PATIENT. J Chronic Dis 1964; 17:57.</a></li><li><a class="nounderline abstract_t">Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297:845.</a></li><li><a class="nounderline abstract_t">Goldman L. Aortic stenosis in noncardiac surgery: underappreciated in more ways than one? Am J Med 2004; 116:60.</a></li><li><a class="nounderline abstract_t">Zahid M, Sonel AF, Saba S, Good CB. Perioperative risk of noncardiac surgery associated with aortic stenosis. Am J Cardiol 2005; 96:436.</a></li><li><a class="nounderline abstract_t">Calleja AM, Dommaraju S, Gaddam R, et al. Cardiac risk in patients aged &gt;75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 2010; 105:1159.</a></li><li><a class="nounderline abstract_t">Tashiro T, Pislaru SV, Blustin JM, et al. Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice. Eur Heart J 2014; 35:2372.</a></li><li><a class="nounderline abstract_t">Kwok CS, Bagur R, Rashid M, et al. Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis. Int J Cardiol 2017; 240:145.</a></li><li><a class="nounderline abstract_t">Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349:343.</a></li><li><a class="nounderline abstract_t">Loscalzo J. From clinical observation to mechanism--Heyde's syndrome. N Engl J Med 2012; 367:1954.</a></li><li><a class="nounderline abstract_t">Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63:e57.</a></li><li><a class="nounderline abstract_t">Torsher LC, Shub C, Rettke SR, Brown DL. Risk of patients with severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol 1998; 81:448.</a></li><li><a class="nounderline abstract_t">Raymer K, Yang H. Patients with aortic stenosis: cardiac complications in non-cardiac surgery. Can J Anaesth 1998; 45:855.</a></li><li><a class="nounderline abstract_t">Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33:2451.</a></li><li><a class="nounderline abstract_t">Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38:2739.</a></li><li><a class="nounderline abstract_t">Okuno T, Demirel C, Tomii D, et al. Risk and Timing of Noncardiac Surgery After Transcatheter Aortic Valve Implantation. JAMA Netw Open 2022; 5:e2220689.</a></li><li><a class="nounderline abstract_t">Levine MJ, Berman AD, Safian RD, et al. Palliation of valvular aortic stenosis by balloon valvuloplasty as preoperative preparation for noncardiac surgery. Am J Cardiol 1988; 62:1309.</a></li><li><a class="nounderline abstract_t">Roth RB, Palacios IF, Block PC. Percutaneous aortic balloon valvuloplasty: its role in the management of patients with aortic stenosis requiring major noncardiac surgery. J Am Coll Cardiol 1989; 13:1039.</a></li><li><a class="nounderline abstract_t">Hayes SN, Holmes DR Jr, Nishimura RA, Reeder GS. Palliative percutaneous aortic balloon valvuloplasty before noncardiac operations and invasive diagnostic procedures. Mayo Clin Proc 1989; 64:753.</a></li><li><a class="nounderline abstract_t">Mittnacht AJ, Fanshawe M, Konstadt S. Anesthetic considerations in the patient with valvular heart disease undergoing noncardiac surgery. Semin Cardiothorac Vasc Anesth 2008; 12:33.</a></li><li><a class="nounderline abstract_t">Christ M, Sharkova Y, Geldner G, Maisch B. Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest 2005; 128:2944.</a></li></ol></div><div id="topicVersionRevision">Topic 8124 Version 16.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25091544" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9060903" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8459080" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16980116" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Burden of valvular heart diseases: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21263455" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Epidemiology of valvular heart disease in the adult.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22942293" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The evolving epidemiology of valvular aortic stenosis. the Tromsøstudy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26754575" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23727214" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10956305" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Interface between valve disease and ischaemic heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23644089" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22299385" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Coronary flow reserve in patients with aortic stenosis and nonobstructed coronary arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9032164" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Does this patient have an abnormal systolic murmur?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9798818" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : A bedside clinical prediction rule for detecting moderate or severe aortic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9924164" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Physical examination in valvular aortic stenosis: correlation with stenosis severity and prediction of clinical outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33332150" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3984868" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Relation of angina pectoris to coronary artery disease in aortic valve stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2801537" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Coronary artery disease in patients 35 years of age or older with valvular aortic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3800187" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Valvular aortic stenosis. A clinical and hemodynamic profile of patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11356405" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15222279" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Crossing the aortic valve in severe aortic stenosis: no longer acceptable?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12699950" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7798533" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Adenosine pharmacologic stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis. Diagnostic efficacy and comparison of clinical, hemodynamic and electrocardiographic variables with 100 age-matched control subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14752468" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Adenosine stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11893828" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Dipyridamole myocardial perfusion tomography in patients with severe aortic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26979307" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : An assessment of the safety, hemodynamic response, and diagnostic accuracy of commonly used vasodilator stressors in patients with severe aortic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14706659" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23481524" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Impact of aortic stenosis on postoperative outcomes after noncardiac surgeries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25614427" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Aortic stenosis and perioperative risk with noncardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14107170" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : SURGICAL RISK IN THE CARDIAC PATIENT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/904659" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Multifactorial index of cardiac risk in noncardiac surgical procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14706670" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Aortic stenosis in noncardiac surgery: underappreciated in more ways than one?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16054477" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Perioperative risk of noncardiac surgery associated with aortic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20381670" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Cardiac risk in patients aged&gt;75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24553722" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28431770" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12878741" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Acquired von Willebrand syndrome in aortic stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23150964" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : From clinical observation to mechanism--Heyde's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24603191" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9485135" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Risk of patients with severe aortic stenosis undergoing noncardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9818108" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Patients with aortic stenosis: cardiac complications in non-cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22922415" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Guidelines on the management of valvular heart disease (version 2012).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28886619" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : 2017 ESC/EACTS Guidelines for the management of valvular heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35797045" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Risk and Timing of Noncardiac Surgery After Transcatheter Aortic Valve Implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2461651" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Palliation of valvular aortic stenosis by balloon valvuloplasty as preoperative preparation for noncardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2926053" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Percutaneous aortic balloon valvuloplasty: its role in the management of patients with aortic stenosis requiring major noncardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2475727" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Palliative percutaneous aortic balloon valvuloplasty before noncardiac operations and invasive diagnostic procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18397904" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Anesthetic considerations in the patient with valvular heart disease undergoing noncardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16236971" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
